Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00543036
Recruitment Status : Unknown
Verified August 2007 by Shalvata Mental Health Center.
Recruitment status was:  Recruiting
First Posted : October 12, 2007
Last Update Posted : October 12, 2007
Information provided by:
Shalvata Mental Health Center

Brief Summary:
Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

Condition or disease Intervention/treatment Phase
Marijuana Abuse Device: H-Coil deep TMS Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

Exclusion Criteria:

  • History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
  • Hamilton depression scale rated 25 and above (moderate to severe depression)
  • Current alcohol or other substance abuse or dependence
  • Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
  • History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
  • Severe somatic co-morbidity
  • History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00543036

Contact: Ziv Carmel, M.D. +972-9-7478570

Shalvata Mental Health Center Recruiting
Hod-HaSharon, Israel, 45100
Contact: Ziv Carmel, M.D    +972-9-7478570   
Principal Investigator: Ziv Carmel, M.D         
Sponsors and Collaborators
Shalvata Mental Health Center
Principal Investigator: Ziv Carmel, M.D Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine
Principal Investigator: Abraham Zangen, Ph.D. Weizmann Institute, Rehovot, Israel Identifier: NCT00543036     History of Changes
Other Study ID Numbers: SH 30107
First Posted: October 12, 2007    Key Record Dates
Last Update Posted: October 12, 2007
Last Verified: August 2007

Keywords provided by Shalvata Mental Health Center:

Additional relevant MeSH terms:
Marijuana Abuse
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders